Cargando…

Natural Products Impacting DNA Methyltransferases and Histone Deacetylases

Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Akone, Sergi Herve, Ntie-Kang, Fidele, Stuhldreier, Fabian, Ewonkem, Monique Bassomo, Noah, Alexandre Mboene, Mouelle, Simon Eitel Misse, Müller, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438611/
https://www.ncbi.nlm.nih.gov/pubmed/32903500
http://dx.doi.org/10.3389/fphar.2020.00992
_version_ 1783572825527812096
author Akone, Sergi Herve
Ntie-Kang, Fidele
Stuhldreier, Fabian
Ewonkem, Monique Bassomo
Noah, Alexandre Mboene
Mouelle, Simon Eitel Misse
Müller, Rolf
author_facet Akone, Sergi Herve
Ntie-Kang, Fidele
Stuhldreier, Fabian
Ewonkem, Monique Bassomo
Noah, Alexandre Mboene
Mouelle, Simon Eitel Misse
Müller, Rolf
author_sort Akone, Sergi Herve
collection PubMed
description Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-coding RNAs. Emerging evidence has revealed that epigenetic dysregulations are involved in a wide range of diseases including cancers. Therefore, the reversible nature of epigenetic modifications concerning activation or inhibition of enzymes involved could be promising targets and useful tools for the elucidation of cellular and biological phenomena. In this review, emphasis is laid on natural products that inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) making them promising candidates for the development of lead structures for anticancer-drugs targeting epigenetic modifications. However, most of the natural products targeting HDAC and/or DNMT lack isoform selectivity, which is important for determining their potential use as therapeutic agents. Nevertheless, the structures presented in this review offer the well-founded basis that screening and chemical modifications of natural products will in future provide not only leads to the identification of more specific inhibitors with fewer side effects, but also important features for the elucidation of HDAC and DNMT function with respect to cancer treatment.
format Online
Article
Text
id pubmed-7438611
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74386112020-09-03 Natural Products Impacting DNA Methyltransferases and Histone Deacetylases Akone, Sergi Herve Ntie-Kang, Fidele Stuhldreier, Fabian Ewonkem, Monique Bassomo Noah, Alexandre Mboene Mouelle, Simon Eitel Misse Müller, Rolf Front Pharmacol Pharmacology Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-coding RNAs. Emerging evidence has revealed that epigenetic dysregulations are involved in a wide range of diseases including cancers. Therefore, the reversible nature of epigenetic modifications concerning activation or inhibition of enzymes involved could be promising targets and useful tools for the elucidation of cellular and biological phenomena. In this review, emphasis is laid on natural products that inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) making them promising candidates for the development of lead structures for anticancer-drugs targeting epigenetic modifications. However, most of the natural products targeting HDAC and/or DNMT lack isoform selectivity, which is important for determining their potential use as therapeutic agents. Nevertheless, the structures presented in this review offer the well-founded basis that screening and chemical modifications of natural products will in future provide not only leads to the identification of more specific inhibitors with fewer side effects, but also important features for the elucidation of HDAC and DNMT function with respect to cancer treatment. Frontiers Media S.A. 2020-08-13 /pmc/articles/PMC7438611/ /pubmed/32903500 http://dx.doi.org/10.3389/fphar.2020.00992 Text en Copyright © 2020 Akone, Ntie-Kang, Stuhldreier, Ewonkem, Noah, Mouelle and Müller http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Akone, Sergi Herve
Ntie-Kang, Fidele
Stuhldreier, Fabian
Ewonkem, Monique Bassomo
Noah, Alexandre Mboene
Mouelle, Simon Eitel Misse
Müller, Rolf
Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title_full Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title_fullStr Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title_full_unstemmed Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title_short Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
title_sort natural products impacting dna methyltransferases and histone deacetylases
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438611/
https://www.ncbi.nlm.nih.gov/pubmed/32903500
http://dx.doi.org/10.3389/fphar.2020.00992
work_keys_str_mv AT akonesergiherve naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT ntiekangfidele naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT stuhldreierfabian naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT ewonkemmoniquebassomo naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT noahalexandremboene naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT mouellesimoneitelmisse naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases
AT mullerrolf naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases